ASX
AVITA Medical, Inc.
AVH:ASX•Healthcare
Sensitive ASX Announcement
AVITA Receives FDA IDE Approval to Evaluate RECELL for Vitil
Published: 30/12/19, 08:22am (AEST)•3 pages